<- Go Home

Probiotec Limited

Probiotec Limited engages in the development, manufacture, packing, distribution, and sale of prescription and over the counter pharmaceuticals, complementary medicines and consumer health products, and fast-moving consumer products in Australia and internationally. The company provides contract manufacturing services for solid dose tablets, capsules, and caplets; tablets coatings; blister packs, bottles, sachets, tubs, and tubes; liquids, creams, gels, lotions, ointments, and powders and powder blends. It is also involved in analytical and stability testing services; new product formulation and production trials, and ongoing research and development services; and packaging options for human and animal nutrition products, as well as manufactures and exports a range of nutraceuticals and functional ingredient raw materials. The company was incorporated in 1996 and is headquartered in Laverton North, Australia. As of June 18, 2024, Probiotec Limited operates as a subsidiary of PYFA Australia Pty Ltd.

Market Cap

AUD 242.3M

Volume

56.2K

Cash and Equivalents

AUD 12.8M

EBITDA

AUD 27.2M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

AUD 66.3M

Profit Margin

29.95%

52 Week High

AUD 3.03

52 Week Low

AUD 2.13

Dividend

N/A

Price / Book Value

2.74

Price / Earnings

28.64

Price / Tangible Book Value

57.11

Enterprise Value

AUD 315.6M

Enterprise Value / EBITDA

9.38

Operating Income

AUD 19.0M

Return on Equity

10.18%

Return on Assets

5.09

Cash and Short Term Investments

AUD 12.8M

Debt

AUD 86.1M

Equity

AUD 88.3M

Revenue

AUD 221.2M

Unlevered FCF

AUD 5.4M

Sector

Pharmaceuticals

Category

N/A

Company Stock Pitches